Ropes Wealth Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,464
Closed -$701K 261
2023
Q2
$701K Sell
7,464
-19
-0.3% -$1.48K 0.12% 144
2023
Q1
$507K Hold
7,483
0.09% 173
2022
Q4
$370K Sell
7,483
-334
-4% -$13.6K 0.07% 195
2022
Q3
$254K Buy
7,817
+110
+1% +$4.54K 0.05% 212
2022
Q2
$304K Hold
7,707
0.06% 210
2022
Q1
$539K Hold
7,707
0.09% 187
2021
Q4
$600K Buy
+7,707
New +$680K 0.11% 147
2021
Q1
Sell
-500
Closed -$66K 427
2020
Q4
$66K Hold
500
0.01% 349
2020
Q3
$51K Hold
500
0.01% 332
2020
Q2
$43K Hold
500
0.01% 322
2020
Q1
$29K Hold
500
0.01% 336
2019
Q4
$46K Hold
500
0.01% 339
2019
Q3
$45K Sell
500
-100
-17% -$11.4K 0.01% 346
2019
Q2
$71K Buy
+600
New +$60.5K 0.02% 301

Other funds holding EXAS

Ropes Wealth Advisors's EXAS Position: Q3 2023 in Review

Ropes Wealth Advisors sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 7,464 shares — an estimated $701K sold.

Ropes Wealth Advisors first reported a position in EXAS in Q2 2019 and held it in 14 quarters. The position peaked at $701K in Q2 2023. 623 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Ropes Wealth Advisors reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Ropes Wealth Advisors sold 7,464 Exact Sciences shares in Q3 2023, an estimated $701K.
  • Ropes Wealth Advisors first reported a position in Exact Sciences in Q2 2019 and held it in 14 quarters.
  • Ropes Wealth Advisors's Exact Sciences position peaked at $701K in Q2 2023.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Ropes Wealth Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.